Study on Anti-Melanoma Mechanism of Sparganii Rhizoma Extract Inhibiting Glycolysis Rate-limiting Enzyme

LIU Yang; ZHENG Xiu-qin; YANG Ge-jun; ZHAO Han; LU Yin; WANG Ai-yun; CHEN Wen-xing

doi:10.14148/j.issn.1672-0482.2022.0331

Volume 38 Issue 4

Apr. 2022

Turn off MathJax

Article Contents

Article Navigation > Journal of Nanjing University of traditional Chinese Medicine > 2022 > 38(4): 331-338

LIU Yang, ZHENG Xiu-qin, YANG Ge-jun, ZHAO Han, LU Yin, WANG Ai-yun, CHEN Wen-xing. Study on Anti-Melanoma Mechanism of Sparganii Rhizoma Extract Inhibiting Glycolysis Rate-limiting Enzyme[J]. Journal of Nanjing University of traditional Chinese Medicine, 2022, 38(4): 331-338. doi: 10.14148/j.issn.1672-0482.2022.0331

Citation:

LIU Yang, ZHENG Xiu-qin, YANG Ge-jun, ZHAO Han, LU Yin, WANG Ai-yun, CHEN Wen-xing. Study on Anti-Melanoma Mechanism of Sparganii Rhizoma Extract Inhibiting Glycolysis Rate-limiting Enzyme[J]. Journal of Nanjing University of traditional Chinese Medicine, 2022, 38(4): 331-338. doi: 10.14148/j.issn.1672-0482.2022.0331

Citation:

LIU Yang, ZHENG Xiu-qin, YANG Ge-jun, ZHAO Han, LU Yin, WANG Ai-yun, CHEN Wen-xing. Study on Anti-Melanoma Mechanism of Sparganii Rhizoma Extract Inhibiting Glycolysis Rate-limiting Enzyme[J]. Journal of Nanjing University of traditional Chinese Medicine, 2022, 38(4): 331-338. doi: 10.14148/j.issn.1672-0482.2022.0331

PDF( 3796 KB)

Study on Anti-Melanoma Mechanism of Sparganii Rhizoma Extract Inhibiting Glycolysis Rate-limiting Enzyme

doi: 10.14148/j.issn.1672-0482.2022.0331

LIU Yang^{1, 2
,},
ZHENG Xiu-qin^{1, 2},
YANG Ge-jun^{1, 2},
ZHAO Han^{1, 2},
LU Yin^{1, 2},
WANG Ai-yun^{1, 2},
CHEN Wen-xing^{1, 2
,
,}

1.
School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China
2.
Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, Nanjing 210023, China

Received Date: 2021-12-15
Available Online: 2022-04-13

Abstract

Abstract

OBJECTIVE To explore the molecular mechanism of Sparganii Rhizome anti-melanoma and its effective material basis. METHODS The active ingredients and corresponding targets of Sparganii Rhizome were retrieved through the Traditional Chinese Medicine System Pharmacology Database and Analysis Platform (TCMSP), and the melanoma disease targets were retrieved by GeneCards database. The drug-disease target protein-protein interaction (PPI) was constructed by the cytoscape 3.7.2 software. The core targets were screened out and uploaded to the DAVID platform for KEGG pathway enrichment analysis. Further verification was carried out through cell proliferation and activity detection (CCK-8) experiment, EdU proliferation testing experiment, Seahorse XF cell mito stress analysis experiment, metabolites and enzyme activity detection kit experiment and Western blot. RESULTS Obtained from the TCMSP database, the five active ingredients in Sparganii Rhizome, corresponding to a total of 70 targets, constructed a PPI network with disease targets and further screened to obtain a key network composed of 86 core targets. The results of enrichment analysis of the KEGG signaling pathway showed that Sparganii Rhizome treatment of melanoma mainly involved metabolic-related pathways, p53 signal pathways, AMPK signal pathways, MAPK signal pathways, PI3K/Akt signal pathways, apoptosis signal pathways, etc. The results of in vitro experiments showed that the Sparganii Rhizome extract (SLTQW) inhibits the proliferation of melanoma A375 cells in a dose-depentent manner and reduces the rate of extracellular acidification of cells and the production of glycolytic metabolites pyruvate, lactic acid, ATP. The results of the kit and Western blot showed that the SLTQW inhibited the activity of PK and reduced the protein expression levels of PKM2, LDHA, MCT4. CONCLUSION SLTQW has obvious anti-melanoma effect, and its mechanism may be related to inhibiting the glycolysis-related proteins PKM2, LDHA, MCT4 expression and interfering with tumor cell glycolysis metabolism.
- Sparganii Rhizome,
- network pharmacology,
- melanoma,
- energy metabolism,
- glycolysis

FullText(HTML)

References(21)

References

[1]	DJAVID AR, STONESIFER C, FULLERTON BT, et al. Etiologies of melanoma development and prevention measures: A review of the current evidence[J]. Cancers, 2021, 13(19): 4914. doi: 10.3390/cancers13194914
[2]	LEONARDI G, FALZONE L, SALEMI R, et al. Cutaneous melanoma: From pathogenesis to therapy (review)[J]. Int J Oncol, 2018, 52(4): 1071-1080.
[3]	林千里, 张文俊, 汪汇, 等. 皮肤黑色素瘤流行病学及防治研究进展[J]. 中国医药导报, 2019, 16(3): 28-32. https://www.cnki.com.cn/Article/CJFDTOTAL-YYCY201903007.htm LIN QL, ZHANG WJ, WANG H, et al. Research progress on epidemiology, treatment and prevention of malignant melanoma of skin[J]. China Med Her, 2019, 16(3): 28-32. https://www.cnki.com.cn/Article/CJFDTOTAL-YYCY201903007.htm
[4]	HANAHAN D, WEINBERG RA. Hallmarks of cancer: The next generation[J]. Cell, 2011, 144(5): 646-674. doi: 10.1016/j.cell.2011.02.013
[5]	PAVLOVA NN, THOMPSON CB. The emerging hallmarks of cancer metabolism[J]. Cell Metab, 2016, 23(1): 27-47. doi: 10.1016/j.cmet.2015.12.006
[6]	倪雯婷, 潘燕红, 王爱云, 等. 破血消癥中药抗肿瘤转移研究进展[J]. 中草药, 2016, 47(24): 4472-4477. doi: 10.7501/j.issn.0253-2670.2016.24.028 NI WT, PAN YH, WANG AY, et al. Research progress in inhibition of Chinese materia medica with breaking blood stasis and resolving mass on tumor metastasis[J]. Chin Tradit Herb Drugs, 2016, 47(24): 4472-4477. doi: 10.7501/j.issn.0253-2670.2016.24.028
[7]	刘运梅, 张连爱. 化银汤治疗寻常型银屑病疗效观察[J]. 陕西中医, 2011, 32(4): 455-456. doi: 10.3969/j.issn.1000-7369.2011.04.042 LIU YM, ZHANG LN. Observation of the efficacy of silver decoction in the treatment of psoriasis vulgaris[J]. Shaanxi J Tradit Chin Med, 2011, 32(4): 455-456. doi: 10.3969/j.issn.1000-7369.2011.04.042
[8]	石杨, 常婧舒, 李秋贵. 李秋贵应用三棱与莪术经验集萃[J]. 世界中西医结合杂志, 2014, 9(2): 133-134, 137. https://www.cnki.com.cn/Article/CJFDTOTAL-SJZX201402010.htm SHI Y, CHANG JS, LI QG. Collection of LI Qiu-gui' s experiences in the application of rhizoma sparganii and rhizoma curcumae[J]. World J Integr Tradit West Med, 2014, 9(2): 133-134, 137. https://www.cnki.com.cn/Article/CJFDTOTAL-SJZX201402010.htm
[9]	李学臣, 张涛, 魏晓东. 三棱提取物对H22荷瘤小鼠的抑瘤作用[J]. 黑龙江医药科学, 2010, 33(5): 78. https://www.cnki.com.cn/Article/CJFDTOTAL-KXJY201005055.htm LI XC, ZHANG T, WEI XD. Tumor suppressant effect of triangular extract on H22 tumor-bearing mice[J]. Heilongjiang Med Pharm, 2010, 33(5): 78. https://www.cnki.com.cn/Article/CJFDTOTAL-KXJY201005055.htm
[10]	刘彬, 符秀琼, 刘慰华, 等. 芒柄花黄素对人黑色素瘤细胞株A375凋亡的影响[J]. 现代中西医结合杂志, 2014, 23(15): 1603-1605. doi: 10.3969/j.issn.1008-8849.2014.15.003 LIU B, FU XQ, LIU WH, et al. Influence of formononetin on apoptosis in A375 Human melanoma cells. [J]. Mod J Integr Tradit Chin West Med, 2014, 23(15): 1603-1605. doi: 10.3969/j.issn.1008-8849.2014.15.003
[11]	郑秀芹. 基于糖酵解限速酶探讨三棱成分山柰酚抗黑色素瘤转移机制[D]. 南京: 南京中医药大学, 2021. ZHENG XQ. Exploring the anti-metastatic mechanism of Sparganium stoloniferum component kaempferol based on glycolysis rate limiting enzyme[D]. Nanjing: Nanjing University of Chinese Medicine, 2021.
[12]	黄琼. LAMTOR1在β细胞胰岛素分泌中的作用及其机制研究[D]. 南昌: 南昌大学, 2019. HUANG Q. The role of LAMTOR1 in islet β cell insulin secretion[D]. Nanchang: Nanchang University, 2019.
[13]	曾红, 陈德宇. 皮肤癌的中西医结合治疗进展[J]. 四川中医, 2015, 33(3): 187-189. https://www.cnki.com.cn/Article/CJFDTOTAL-SCZY201503092.htm ZENG H, CHEN DY. Treatment progress of using integrative therapy in skin cancer[J]. J Sichuan Tradit Chin Med, 2015, 33(3): 187-189. https://www.cnki.com.cn/Article/CJFDTOTAL-SCZY201503092.htm
[14]	CHENG L, SHI L, WU J, et al. A hederagenin saponin isolated from Clematis ganpiniana induces apoptosis in breast cancer cells via the mitochondrial pathway[J]. Oncol Lett, 2018, 15(2): 1737-1743.
[15]	BIN SAYEED MS, AMEEN SS. Beta-sitosterol: A promising but orphan nutraceutical to fight against cancer[J]. Nutr Cancer, 2015, 67(8): 1216-1222.
[16]	LO YL, WANG W. Formononetin potentiates epirubicin-induced apoptosis via ROS production in HeLa cells in vitro[J]. Chem Biol Interact, 2013, 205(3): 188-197.
[17]	HU W, WU XP, TANG JD, et al. In vitro and in vivo studies of antiosteosarcoma activities of formononetin[J]. J Cell Physiol, 2019, 234(10): 17305-17313.
[18]	WANG AI-LEI, LI Y, ZHAO Q, et al. Formononetin inhibits colon carcinoma cell growth and invasion by microRNA-149-mediated EphB3 downregulation and inhibition of PI3K/AKT and STAT3 signaling pathways[J]. Mol Med Report, 2018, 17(6): 7721-7729.
[19]	张硕, 岳旺, 王蕾, 等. 白花蛇舌草豆甾醇对肝癌细胞的体内外抑制作用及对其增殖周期、凋亡的影响[J]. 现代生物医学进展, 2008, 8(11): 2016-2017, 2009. https://www.cnki.com.cn/Article/CJFDTOTAL-SWCX200811007.htm ZHANG S, YUE W, WANG L, et al. Inhibitive effect of Stigmasterol from Hedyotis diffusa willd, on hepatoma cells in vitro & vivo and its influence on transplanted H22 tumor cell's multiplication cycle, apoptosis[J]. Prog Mod Biomed, 2008, 8(11): 2016-2017, 2009. https://www.cnki.com.cn/Article/CJFDTOTAL-SWCX200811007.htm
[20]	KOCH A, EBERT EV, SEITZ T, et al. Characterization of glycolysis-related gene expression in malignant melanoma[J]. Pathol Res Pract, 2020, 216(1): 152752.
[21]	RUOCCO MR, AVAGLIANO A, GRANATO G, et al. Metabolic flexibility in melanoma: A potential therapeutic target[J]. Semin Cancer Biol, 2019, 59: 187-207.

Relative Articles

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(9) / Tables(1)

Get Citation

PDF

XML

Article Metrics

Article views (230) PDF downloads(21)

Study on Anti-Melanoma Mechanism of Sparganii Rhizoma Extract Inhibiting Glycolysis Rate-limiting Enzyme

doi: 10.14148/j.issn.1672-0482.2022.0331

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Study on Anti-Melanoma Mechanism of Sparganii Rhizoma Extract Inhibiting Glycolysis Rate-limiting Enzyme

doi: 10.14148/j.issn.1672-0482.2022.0331

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Export File

Citation

Format

Content